DANIEL G WELCH Insider Trading $RARE Ultragenyx Pharmaceutical Inc.
Get free email notifications about insider trading for DANIEL G WELCH.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DANIEL G WELCH. DANIEL G WELCH is CEO and President in INTERMUNE INC ($ITMN) and Chairman, CEO and President in INTERMUNE INC ($ITMN) and President & CEO in INTERMUNE INC ($ITMN) and President and CEO in INTERMUNE INC ($ITMN) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and Director in HYPERION THERAPEUTICS INC ($HPTX) and in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in AveXis, Inc. ($AVXS) and Director in Nuvation Bio Inc. ($PANA).
DANIEL G WELCH in Ultragenyx Pharmaceutical Inc.
Trading Symbol: RAREIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DANIEL G WELCH: Director
Holdings: 12,300 shares
Current Value: $896,793
Latest Transaction: Jun 30 2020
$RARE Market Capitalization: $2.92B
$RARE Previous Close: $72.91
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of DANIEL G WELCH in Ultragenyx Pharmaceutical Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AVXS, HPTX, ICPT, ITMN, NUVB, SGEN, RARE
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 30 2020 | RARE | Ultragenyx Pharmac ... | WELCH DANIEL G | Director | Option Exercise | A | 76.58 | 4,250 | 325,465 | 4,250 | |
Jun 30 2020 | RARE | Ultragenyx Pharmac ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 2,550 | 0 | 12,300 | 9.8 K to 12.3 K (+26.15 %) |
Jun 13 2019 | RARE | Ultragenyx Pharmac ... | WELCH DANIEL G | Director | Option Exercise | A | 58.74 | 5,000 | 293,700 | 5,000 | |
Jun 13 2019 | RARE | Ultragenyx Pharmac ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 3,000 | 0 | 9,750 | 6.8 K to 9.8 K (+44.44 %) |
Jun 20 2018 | RARE | Ultragenyx Pharmac ... | WELCH DANIEL G | Director | Option Exercise | A | 80.69 | 5,000 | 403,450 | 5,000 | |
Jun 20 2018 | RARE | Ultragenyx Pharmac ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 3,000 | 0 | 6,750 | 3.8 K to 6.8 K (+80.00 %) |
Jun 22 2017 | RARE | Ultragenyx Pharmac ... | WELCH DANIEL G | Director | Option Exercise | A | 65.66 | 3,750 | 246,225 | 3,750 | |
Jun 22 2017 | RARE | Ultragenyx Pharmac ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 1,875 | 0 | 3,750 | 1.9 K to 3.8 K (+100.00 %) |
Jun 14 2016 | RARE | Ultragenyx Pharmac ... | WELCH DANIEL G | Option Exercise | A | 65.85 | 3,750 | 246,938 | 3,750 | ||
Jun 14 2016 | RARE | Ultragenyx Pharmac ... | WELCH DANIEL G | Grant | A | 0.00 | 1,875 | 0 | 1,875 | 0 to 1.9 K | |
Jun 22 2015 | RARE | Ultragenyx Pharmac ... | WELCH DANIEL G | Option Exercise | A | 97.85 | 7,500 | 733,875 | 7,500 | ||
Apr 10 2015 | RARE | Ultragenyx Pharmac ... | WELCH DANIEL G | Director | Option Exercise | A | 59.95 | 17,500 | 1,049,125 | 17,500 |
Page: 1